Guardian Pharmacy Services, Inc.
GRDN · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $377,427 | $344,334 | $329,308 | $338,569 |
| % Growth | 9.6% | 4.6% | -2.7% | – |
| Cost of Goods Sold | $302,706 | $276,188 | $264,959 | $271,465 |
| Gross Profit | $74,721 | $68,146 | $64,349 | $67,104 |
| % Margin | 19.8% | 19.8% | 19.5% | 19.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $58,367 | $55,566 | $51,344 | $50,349 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $58,367 | $55,566 | $51,344 | $50,349 |
| Operating Income | $16,354 | $12,580 | $13,005 | $16,755 |
| % Margin | 4.3% | 3.7% | 3.9% | 4.9% |
| Other Income/Exp. Net | $277 | $7 | $101 | -$534 |
| Pre-Tax Income | $16,631 | $12,587 | $13,106 | $16,221 |
| Tax Expense | $7,038 | $3,760 | $3,833 | $4,380 |
| Net Income | $9,818 | $9,030 | $9,448 | $11,943 |
| % Margin | 2.6% | 2.6% | 2.9% | 3.5% |
| EPS | 0.16 | 0.15 | 0.15 | 0.2 |
| % Growth | 6.7% | 0% | -25% | – |
| EPS Diluted | 0.15 | 0.14 | 0.15 | 0.2 |
| Weighted Avg Shares Out | 62,124 | 62,046 | 62,043 | 61,143 |
| Weighted Avg Shares Out Dil | 63,432 | 63,203 | 62,914 | 61,143 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $160 | $172 | $170 | $421 |
| Depreciation & Amortization | $6,816 | $5,489 | $5,267 | $5,153 |
| EBITDA | $23,607 | $18,248 | $18,543 | $21,795 |
| % Margin | 6.3% | 5.3% | 5.6% | 6.4% |